Dulaglutide Depot (Mapi Pharma)

长效度拉糖肽 (Mapi Pharma)

Report date: 2024/03/15 17:36:44

Base Information

Drug NameDulaglutide Depot (Mapi Pharma)
Drug Alias Nameimproved once weekly Trulicity (Mapi Pharma)
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein > Fc fusion protein
Mechanisms of ActionGlucagon-like peptide 1 receptor agonists
TargetsGlucagon-like peptide 1 receptor
Therapy Area/IndicationsDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMapi Pharma Ltd
China Registration ClassN/A

Develop Information

Active CompaniesMapi Pharma Ltd
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A